Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Links between personality functioning and post-traumatic stress disorder symptoms: a network analysis.

European journal of psychotraumatology·2026
Same author

How personality functioning shapes symptom development during and after treatment: A random intercept cross lagged panel analysis.

Comprehensive psychiatry·2026
Same author

Trauma and resilience among non-displaced in the early phase of the war in Ukraine.

Scientific reports·2026
Same author

Long-Term Effectiveness of Inpatient and Day-Hospital Treatment of Eating Disorders in Departments of Psychosomatic Medicine and Psychotherapy in Germany.

European eating disorders review : the journal of the Eating Disorders Association·2026
Same author

Common practice elements of cognitive behavioral therapy for gaming disorder: A systematic review and expert panel evaluation.

Clinical psychology review·2026
Same author

Beyond early termination: Predicting quality-related vs. quality-neutral dropout during the active phase of outpatient cognitive behavioral therapy.

Psychotherapy research : journal of the Society for Psychotherapy Research·2026

Related Experiment Videos

Behavioral medicine interventions in diabetes.

Kristin Plack1, Stephan Herpertz, Frank Petrak

  • 1Department of Clinical Psychology and Psychotherapy, Johannes Gutenberg-University of Mainz, Mainz, Germany. kplack@uni-mainz.de

Current Opinion in Psychiatry
|January 9, 2010
PubMed
Summary

Behavioral medicine interventions improve diabetes management by enhancing self-care and reducing psychological distress. These approaches effectively lower HbA1c and boost patient confidence, particularly for those with high distress levels.

Related Experiment Videos

Area of Science:

  • Behavioral Medicine
  • Endocrinology
  • Psychology

Background:

  • Poor glycemic control significantly impacts diabetes patient outcomes.
  • Patient self-management is crucial for successful diabetes treatment.
  • Behavioral interventions target self-management, coping, and stress reduction.

Purpose of the Study:

  • Review randomized controlled trials (RCTs) of behavioral medicine interventions for diabetes.
  • Evaluate effects on metabolic control, medical variables, self-management, and psychological outcomes.
  • Focus on RCTs published between March 2008 and September 2009.

Main Methods:

  • Systematic review of recent randomized controlled trials.
  • Analysis of interventions targeting diabetes self-management and psychological well-being.
  • Assessment of outcomes including glycated hemoglobin (HbA1c).

Main Results:

  • Behavioral interventions show beneficial effects on metabolic control, reducing HbA1c.
  • Positive impacts observed in diabetes self-efficacy, self-management, and coping strategies.
  • Interventions effectively reduce psychological burdens and symptoms in patients.

Conclusions:

  • Behavioral medicine interventions are effective for diabetes treatment.
  • These interventions are particularly beneficial for patients with high distress or coping difficulties.
  • Improved blood glucose awareness is a key outcome for certain interventions.